A respiratory consultant from Leicester’s Hospitals has been elected to join the prestigious Fellowship of the Academy of Medical Sciences.
Ground-breaking space technology receives real-life health application
A team from Leicester’s Hospitals and the University of Leicester has been awarded £2 million by the UK Space Agency to develop a new mobile application providing disease specific exercise advice.
New diet and activity research collaboration tackles obesity and chronic disease challenge
The nation’s world-leading researchers in nutrition and physical activity have pledged to work together to tackle challenges associated with obesity and sedentary behaviours.
New clues about why non-smokers, as well as smokers, develop chronic lung disease revealed
A group of researchers led by the Universities of Leicester and Nottingham has discovered genetic differences that put some people at higher risk than others of developing chronic lung disease.
Asthma pill targets airway muscles to decrease attacks
Results from a phase II clinical trial, experimental work on cells and computational modelling have together shown why the first pill for asthma in 20 years can help reduce asthma attacks.
Researchers from Leicester (UK) and Vancouver (Canada) have shown that the investigational drug, Fevipiprant (an oral, selective prostaglandin D2 receptor antagonist), reduces the amount of smooth muscle in the airway lining. The findings are published in Science Translational Medicine today (13 February).
Rapid blood pressure lowering safe for clot-buster-treated stroke patients
A major international study has found that rapidly lowering blood pressure safely reduces the risk of bleeding in the brain in stroke patients being treated with clot-busting drugs. The research, which was led in the UK by the University of Leicester and funded by the Stroke Association, will be published today (7 February) in The Lancet.